Strides to acquire 18 abbreviated new drug applications from Pharmaceutics International, Inc

Strides will significantly expand its niche offerings on its front-end, which has grown multi-fold to attain a quarterly revenue size of USD 66 million.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/377WqdA
via IFTTT